Gene · 2173
Papers2,926
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,926
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy. | Biomedicines | 2021 | 34067791 | PubTator, text mining | PubMed |
| ACSA-2 and GLAST classify subpopulations of multipotent and glial-restricted cerebellar precursors. | J Neurosci Res | 2021 | 34060113 | PubTator, text mining | PubMed |
| The transcriptional repressor Rev-erbα regulates circadian expression of the astrocyte Fabp7 mRNA. | Curr Res Neurobiol | 2021 | 34056625 | PubTator, text mining | PubMed |
| Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. | Redox Biol | 2021 | 34030117 | PubTator, text mining | PubMed |
| Analysis of multi-omics differences in left-side and right-side colon cancer. | PeerJ | 2021 | 34026368 | PubTator, text mining | PubMed |
| Super resolution microscopy reveals DHA-dependent alterations in glioblastoma membrane remodelling and cell migration. | Nanoscale | 2021 | 34018532 | PubTator, text mining | PubMed |
| Cell-type-specific effects of genetic variation on chromatin accessibility during human neuronal differentiation. | Nat Neurosci | 2021 | 34017130 | PubTator, text mining | PubMed |
| Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology. | Biosci Rep | 2021 | 34002799 | PubTator, text mining | PubMed |
| Transcriptome Analyses Reveal IL6/Stat3 Signaling Involvement in Radial Glia Proliferation After Stab Wound Injury in the Adult Zebrafish Optic Tectum. | Front Cell Dev Biol | 2021 | 33996824 | PubTator, text mining | PubMed |
| Triple-negative breast cancer: A run-through of features, classification and current therapies. | Oncol Lett | 2021 | 33986872 | PubTator, text mining | PubMed |
| Genomic and Hormonal Biomarkers of Phthalate-Induced Male Rat Reproductive Developmental Toxicity Part II: A Targeted RT-qPCR Array Approach That Defines a Unique Adverse Outcome Pathway. | Toxicol Sci | 2021 | 33983380 | PubTator, text mining | PubMed |
| Tumor Spheroids of an Aggressive Form of Central Neurocytoma Have Transit-Amplifying Progenitor Characteristics with Enhanced EGFR and Tumor Stem Cell Signaling. | Exp Neurobiol | 2021 | 33972466 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Vascular Senescence: A Potential Bridge Between Physiological Aging and Neurogenic Decline. | Front Neurosci | 2021 | 33958987 | PubTator, text mining | PubMed |
| Effects of Low-Dose Gestational TCDD Exposure on Behavior and on Hippocampal Neuron Morphology and Gene Expression in Mice. | Environ Health Perspect | 2021 | 33956508 | PubTator, text mining | PubMed |
| GSK3ß inhibitor CHIR 99021 modulates cerebral organoid development through dose-dependent regulation of apoptosis, proliferation, differentiation and migration. | PLoS One | 2021 | 33951093 | PubTator, text mining | PubMed |
| An immune-related signature that to improve prognosis prediction of breast cancer. | Am J Cancer Res | 2021 | 33948357 | PubTator, text mining | PubMed |
| The Pharmacological or Genetic Blockade of Endogenous De Novo Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells. | Front Oncol | 2021 | 33928023 | PubTator, text mining | PubMed |
| BLBP Is Both a Marker for Poor Prognosis and a Potential Therapeutic Target in Paediatric Ependymoma. | Cancers (Basel) | 2021 | 33925302 | PubTator, text mining | PubMed |
| Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction. | Int J Mol Sci | 2021 | 33923299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2173/papers?page=29